Marburg Vaccine Testing Accelerated in Rwanda
Amidst a Marburg virus outbreak in Rwanda, vaccine testing is being fast-tracked. The cAd3-Marburg vaccine, developed by NIAID and tested in phase 1 trials last year, showed promising results with no severe adverse effects. However, its practical effectiveness remains untested. Phase 2 clinical tria